CMECME Group

$305.71+20% 1Y

CME as reported

CME Group reported $6.77B of revenue over the trailing twelve months, +5.1% on the year before. 10 reported series are charted on this page, each one as filed.

$6.77B

Revenue, trailing twelve months · to Q2 2026 · +5.1% against the twelve months before

Net income
$4.29B

Net income · +14% year on year · trailing twelve months to Q2 2026

Free cash flow
$4.21B

Free cash flow · +2.6% year on year · trailing twelve months to Q2 2026

Operating margin
65%

Operating margin · trailing twelve months to Q2 2026

Details›
Every series Ryufin has for CME, trailing twelve months
SeriesLatestYear on yearAs of
Revenue$6.77B+5.1%Q2 2026
Net income$4.29B+14%Q2 2026
EPS$11.79+14%Q2 2026
Operating margin65%n/aQ2 2026
Net margin63%n/aQ2 2026
ROE15%n/aQ2 2026
ROA2.1%n/aQ2 2026
ROIC12%n/aQ2 2026
Free cash flow$4.21B+2.6%Q2 2026
P/E25.9n/atoday

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.

CME Group logo
Revenue and profitCME Group (CME)
RevenueNet incomeTrailing twelve months
Powered byryufin.com